chrisvoncsefalvay/vaers-outcomes huggingface dataset:
blood sugar is high/ blood sugar was at 400/ blood sugar is high and it was at 400 and she keeps pumping; This is a spontaneous report received from a contactable reporter(s) (Pharmacist) from medical information team.  A 76-year-old female patient received bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), as dose number unknown, single (Lot number: HH7595, Expiration Date: 31Dec2024) at the age of 76 years intramuscular, in left deltoid for covid-19 immunisation. The patient's relevant medical history included: "Type 1 diabetes" (ongoing). Concomitant medication(s) included: SYNTHROID; BUPROPION; INSULIN ASPART. The following information was reported: BLOOD GLUCOSE INCREASED (non-serious), outcome "unknown", described as "blood sugar is high/ blood sugar was at 400/ blood sugar is high and it was at 400 and she keeps pumping". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were taken as a result of blood glucose increased.  Additional Information HCP called for patient who got the new Pfizer Covid-19 Vaccine and now her blood sugar is high and now caller is asking for recommendation. Pharmacist stated that a patient received the Comirnaty 2023-2024 Formula, NDC 00069-2362-10.  The patient has Type 1 diabetes and on a pump.  Her blood sugar was at 400 and she keeps pumping and it went down to 300.  Female patient; age=76 years old. DSU: E-transmitting possible duplicate. Response: Reviewed/Discussed per PI and attached SRD noting no specific warnings/precautions nor reports of blood sugar changes (searched: glucose, sugar, hyperglycaemia, hypoglycaemia).  It was not noted among common side effects.  Shared amount of sucrose per description section.  Will forward for further research on incidence, as requested.  Noted that we would not have specific recommendations and patient would be referred back to her provider for additional discussion.  When probed for medical conditions and concomitant medications: Reporter stated, "Synthroid, Bupropion she is on Insulin Aspart 100 unit per ml so, there is 90 unit in the pump." When probed for lab test: Reporter stated, "I cannot confirm if she has got any lab test although she did have an appointment last week. I see she does have another appointment." She wants to get most probably COVID vaccine to prevent COVID."  No follow-up attempts are possible. No further information is expected.
Patients get the vaccines which were previously shaken; Vaccine boxes are not secured in the refrigerator; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a nurse and describes the occurrence of PRODUCT PREPARATION ISSUE (Patients get the vaccines which were previously shaken) and EXPIRED PRODUCT ADMINISTERED (Vaccine boxes are not secured in the refrigerator) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT PREPARATION ISSUE (Patients get the vaccines which were previously shaken) and EXPIRED PRODUCT ADMINISTERED (Vaccine boxes are not secured in the refrigerator). At the time of the report, PRODUCT PREPARATION ISSUE (Patients get the vaccines which were previously shaken) and EXPIRED PRODUCT ADMINISTERED (Vaccine boxes are not secured in the refrigerator) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. No treatment information provided.
Per records, pt needed IPV and HBV and was given. When entered to record these vaccines, patient had received them, Upon further research into records, our former employee, later fired, had entered DTaP only instead of the PEDIARIX that had actually been given. I attempted to call the home and mobile numbers 4 times yesterday, including one at 7:40 pm. And again, no response this am so I left a msg on the home phone. Mom's voice box was full on her cell. I explained what happened, told her we would remove any charges, apologized for our error I forgot to mention that we would be reporting this to VAERS.
On 21Apr21, (Name) reported to me (Name) that he has had joint pain since his first shot 27Mar.; This is a spontaneous report from a contactable consumer. A 51-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number: ER2613), via an unspecified route of administration, administered in left arm (reported as unsure) on 27Mar2021 (at the age of 51 years) as dose 1, single for COVID-19 immunization. The patient's medical history included COVID prior vaccination. The patient's concomitant medications were not reported. The patient did not receive any other vaccine in four weeks. The patient's other medications in two weeks were unknown. It was unknown if COVID tested post vaccination. On 21Apr2021 the patient mentioned having joint pain since his first shot on 27Mar2021. The patient did not receive any treatment for the event. The outcome of the event was unknown.  No follow-up attempts are required. No further information is expected.
Rash, lump warm to touch, itchy, Temperature at injection site on arm 100.6. Body temp 97.5.
Systemic: Allergic: Rash Generalized-Medium, Additional Details: Patient developed a full body rash several days after vaccination.  She visited the doctor on 12/3/21 and was given a prescription for a corticosteroid.
Hyperkalemia - vomiting nonstop, increased heartbeat, sweating and hard to breathe
no adverse effects; patient who was close to 50 years old was oin the pharmacy and was administered GARDASIL 9; This spontaneous report was received from a pharmacist, via a company representative, referring to an adult patient of unknown gender, who was close to 50 years old. The patient's pertinent medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not provided.    The last year, on an unspecified date in 2018, the patient was administered hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) for prophylaxis. No adverse effects were reported.
Patient given the adult dosage/formulation of the Pfizer COVID-19 vaccine instead of the pediatric dosage.
When patient presented for her second Pfizer dose, she reported that about two hours after receiving her first dose, she experienced a sensation of numbness of her tongue that lasted for about two hours. She denied any swelling of her lips or tongue, or any other symptoms. She reported that she could still taste. The sensation self-resolved. Given that this was a public health clinic site with limited medical capabilities, we referred her to receive her second vaccination in a medical setting.
Dose administered too soon Narrative: Second dose in COVID-19 Vaccination series administered too soon. Patient did not have reaction as a result. Per CDC guidance, doses inadvertently administered earlier than the grace period should not be repeated.
Vaccinated at 8:20AM started to feel dizzy and swelling in the throat 5 minutes later. Escorted via ambulation to bed, Benadryl 50mg po given. BP 120/78 HR 90. Color pink no swelling of the face tongue or throat noted. NP responded and transferred patient to Primary Care office.  After observation, provided prescriptions for Prednisone, Atarax, Pepcid, already had Epi Pen at home.  Able to go home and reported still feeling dizzy the next day via telephone.
A group of 20-30 pt recvd 3 doses of Engerix-B & it was determined that approx 25% of the pts did not seroconvert p/a 3rd dose; 4th dose of Engerix-B was given & 2 pts still did not seroconvert p/a 4th dose;
Pt vaccinated w/TD/Pneumococcal developed itching & "little bumps" on lt arm around injection site, per pt phone call, pt refused to come for appointment.
Information has been received from a Registered Nurse concerning a 9 year old female patient with no pertinent medical history and no drug reactions or allergies who on 08-FEB-2011 was vaccinated with second dose of VARIVAX (Merck) (lot no. 668454/1043Z, exp date 11-APR-2012) 0.5 mL subcutaneously in the left arm. The patient received the first dose of VARIVAX (Merck) on 14-OCT-2002. On an unspecified date, the patient developed a 3 inch in diameter, red, swollen, hive like (rather than cellulitis) injection site reaction that was painful and itchy (no rash noted) following the second vaccination with VARIVAX (Merck). The patient was seen in the office on 10-FEB-2011 and was told to ice the area. No laboratory diagnostics studies were performed. No improvement to the injection site reaction was noted on 11-FEB-2011. At the time of this report, the patient's outcome was not recovered. Additional information has been requested.
Sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), administered in arm left, administration date 08Jan2021 at 14:15 (Batch/Lot number: unknown) at the age of 55 years as dose 1, single for COVID-19 immunisation. Family history included: "Allergies: Pollen", start date: 1996 (unspecified if ongoing); "Asthmatic", start date: 1996 (unspecified if ongoing); "Animal dander", start date: 1996 (unspecified if ongoing). The patient's concomitant medications were not reported.  The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 08Jan2021 17:00, outcome "recovered" (29Jan2021), described as "Sore arm". Therapeutic measures were not taken as a result of pain in extremity.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Swelling and redness at injection site described by mom as the size of an orange.  No signs of fever or irritability. Medical provider advised that mother continue to monitor site and report any further symptoms. Advised that mom can apply ice to injection site or administer ibuprofen to help reduce swelling or discomfort.
pt recv 2nd dose of vax MAR96 & approx 12JUN96 IgG titer levels were undetectable;
Hospitalized; This case was reported by a consumer via interactive digital media and described the occurrence of adverse drug reaction in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, several days after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced adverse drug reaction (serious criteria hospitalization). On an unknown date, the outcome of the adverse drug reaction was unknown.   It was unknown if the reporter considered the adverse drug reaction to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The case was reported by reporter's neighbour. The age at vaccination was not reported. The patient was hospitalized just days after receiving the Flu vaccine. It was reported that, the doctors said same thing it was a coincidence. The reporter felt that the doctors were lying through their teeth. As far as the whooping cough was concerned, the people were being injected then shedding the vaccine. It was reported that, if the reporter was obviously coughing and knew was sick, I would not be around a baby, or an elderly person. It was reported that, when you were vaccinated, there may be no symptoms, until had been already infected by another person. This is 1 of the 3 cases reported by the same reporter.
Child woke up from her nap and awoke crying. Mother noticed that left leg looked red and swollen, no fever, there is no family history of reaction to immunizations. The child had her 2month immunizations on 04/06/2005.
Sensation of cold rain on back of hands and left side of face lasting several seconds to a minute several times since  vaccinated,   Whole body rash 34 hours after vaccination.  Large red bumps back of neck both arms and legs
Patient called today to report her adverse event. Patient reports several hours after getting her vaccines being at the ER for stroke like symptoms. Patient reports that after several test were performed they confirmed she had sustained a stroke. Patient was hospitalized for 9 days including rehab.
Patient states that he noticed pain and swelling at site. Swelling increased throughout the day and began to get warm and itch. Patient states he then began to notice joint pain in elbows and knees. Unkown if related.
Extreme fatigue that just won't stop.  Headache and body aches.  The fatigue is over whelming to the point it almost caused me to crash my vehicle on the way to work twice.  It has caused me to miss work because the tiredness is overwhelming.  It just doesn't seem to stop.
This spontaneous report as received from a licensed practical nurse refers to unknown number of patient of unknown age and gender. On an unknown date, the unknown number of patients may have been vaccinated with M-M-R II or VAQTA which was stored at higher than recommended temperatures. No adverse effect reported. Additional information has been requested.
I had my vaccination on 10/14/2022. I started to have a runny hose and headache on 03/04/2023. I went to an appointment for a physical on 03/09/2023 and was told it was allergies. A few days later I had to leave work and go to the emergency room. I was given IV fluids and tested COVID-19 Positive on 03/12/2023. I was not provided medication as I was too young. I am still suffering from Asthma on 04/17/2023 and my voice is still hoarse with a dry cough.
Limited mobility and Weakness in left arm that is still an issue three months later.  Discussed first time with PC doctor on 5/18/2021. Shoulder X-ray taken on 5/18, but no issues detected in any area of the shoulder.
This spontaneous report as received from a physician to 2 patients of unknown age and gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On an unknown date, the patients were vaccinated with doses of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) (strength, dose, frequency, route of administration, lot # and expiration date were not reported). On an unknown date, the patients experienced orchitis. The outcome of orchitis was unknown. The relatedness between vaccination with measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (manufacturer unknown) and the event was not reported. This is one of several reports received from the same reporter. Additional information is not expected because there was not contact details to the physician.
fever, sore throat, severe headache, chest pains, severe cough, lethargic, fatigue, black eyes, chest pains, high heart rate
Started taking typhoid (VIVOTIF) #1 Fri May 6. Dose #2 my May 8. On 5/10 evening began to feel nausea & generalizing itching. SOB negative. Noticed at 10:15 had hives buttock & knees - to ER. Took BENADRYL. Stopped typhoid on 5/11. Still with hives - continue with BENADRYL.
A non-serious spontaneous report of received expired FLUMIST was received from a health professional concerning a four-year-old female. Neither medical history nor concomitant medication was reported for this patient. The product expired on 08-Dec-2010. On 13-Dec-2010, the patient received the expired FLUMIST. There was no adverse event associated with this medication error; therefore, treatment and reporter causality assessments are not applicable, and the event was considered resolved. This case will be submitted in accordance with MedImmune's FLUMIST post-marketing commitment for the indicated population of 2 years to 59 months of age. Additional information received on 03-Mar-2011 and incorporated into case: no late occurring adverse events.
Blood in stool starting day after Rotavirus vaccine given. Neg. w/u for intussusception. Neg stool Rota & bacterial culture. Being followed now by GI.
Tingling around lips that started about 45 minutes after the vaccine. Lasted about 1/2 hour. Soreness around injection site the next 2 days.
After receiving the vaccine I was fine that evening and the following morning as well. I would say that it was around 12pm the next day when I started to feel  hot and achy and felt just completely drained. I literally felt so tired to the fact that I couldn't do anything or  move. I was falling asleep while everyone was talking to me.  I went all day without eating and felt the same when  when I woke up the next day. I would say a 24 hour period of no energy and feeling very hot and I did not have the motivation to do anything and my entire body was very achy. I did not physically seek medical help but I called the 24 hour nurse hotline and that's when they advised me to take tylenol for the symptoms I was experiencing.
right ear began to hurt; eustachian tube inflammation; slight vertigo; metallic taste in mouth; phlegm drainage in throat; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EL3247), via an unspecified route of administration (left arm) on 20Jan2021 (15:00) at single dose for Covid-19 immunization. Medical history included penicillin allergy (Known allergies: penicillin, ciprofloxin, levofloxacin, hylan G-F, lexapro, bacitracin). Concomitant medication included potassium chloride. The patient previously took Ciprofloxin, Levofloxacin, Hylan G-F, Lexapro, and Bacitracin and experienced allergy. The patient was not diagnosed with COVID-19 prior to vaccination. The patient is not pregnant. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 22Jan2021 (10:00), the patient began to experience slight vertigo accompanied by metallic taste in mouth and phlegm drainage in throat (reported as "phlym"). When she laid down in bed at right side mainly her vertigo got worse. Late Saturday afternoon (23Jan2021), her right ear began to hurt. She went to urgent care at 7:30 pm. The doctor prescribed vertigo exercises, Flonase nasal spray for possible eustachian tube inflammation and ibuprophin. On Sunday (24Jan2021: today), the patient was still experiencing pretty severe vertigo; not much improved. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The patient had vertigo exercises, ibuprophin, and Flonase spray as treatment. The outcome of events was not recovered. The patient has not been tested for COVID-19 since the vaccination.
pt recv 3 doses of vax. after 3rd vax, exp lt arm atrophy at injection site;
Client reported difficulty breathing, in distress/anxious. VSS. Relaxed on cot under EMS supervision for 10 minutes.
rapid heart beat; fever; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid heart beat) and PYREXIA (fever) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     No Medical History was provided by the reporter.  Concomitant products included ATORVASTATIN CALCIUM (STATIN [ATORVASTATIN CALCIUM]) for High cholesterol.   On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 28-Jan-2021, the patient experienced HEART RATE INCREASED (rapid heart beat) and PYREXIA (fever). The patient was treated with PARACETAMOL (TYLENOL) 28-Jan-2021 for Fever, at a dose of 1 dosage form. On 29-Jan-2021, HEART RATE INCREASED (rapid heart beat) had resolved. At the time of the report, PYREXIA (fever) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In December 2020, SARS-CoV-2 test positive: positive Positive. On 28-Jan-2021, Body temperature: 99.4 (High) high. On 29-Jan-2021, Body temperature: 99.9 (High) high.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
My daughter received her first vaccine on June 10th. She felt ok after receiving it. After her second dose , two weeks later, she seemed ok. Her arm was sore, but that seemed to be about it. A few weeks later it went from muscle soreness to extreme fatigue and flu like symptoms. I took her to the doctor and they said it was a virus. A week later she was still feeling badly but the doctor, tested her for Covid and strep previously, still stated that it was a virus  but gave her some medicine because we were traveling by plane in a few days and her ears felt blocked. She did not get worse on the medicine, her ears seemed to clear and that was about it. She still felt tired and run down. The fatigue,  progressively got worse, the muscle aches, headaches and nausea increasingly kept getting worse. We saw the pediatrician on numerous occasions and reached out to her allergist. We had numerous blood panels and tests and nothing came up. She progressively got these symptoms and they worsened in severity up until September. She still has these symptoms but they aren?t getting worse. We have seen a rheumatologist, the primary care dr, her allergist.  She is now on xolair(er uticaria was under control with Allegra before this) and now we are set to see a cardiologist this month because her heart rate and blood flow seem to be off. All of his started after her second dose of the vaccine. We have all of the appts in our health portal and they all coincide with after she got the second dose of the vaccine
A physician reported via a Co representative, that post vaccine pt experienced pain upon administration. Follow up information received from the physician on 03/08/2001 stated that the physician does not know the specific identity of these patients. The nurses administering Prevnar reported the adverse events described to the physician, plus increased immediate crying post-immunization.
Post vax, the patient experienced a mild case of chicken pox. Unspecified medical attention was sought for the child.
Fatigue and a few days later severe joint pain. 09/30/2014 doctor prescribed Naproxen 500 mg for pain and inflammation. No result so 10/8/2014 returned to doctor to have blood drawn and received steroid shot. Steroid shot has so far ended the joint pain. Hope it is a permanent fix.
Patient was here for a nurse visit for vaccinations today. He was accompanied by his father. The patient was very nervous and worked up about the injections. The Patient was to be given 2 vaccinations today. He was being given a HEP A vaccine and a HPV 9. I administered the Hep A first and it was a successful procedure. When I tried to administer the HPV9 injection, the needle was bad and I could not push the plunger up into the syringe to administer any medication into the patient. I removed the injection and covered the spot with a Band-Aid. I showed the patient and his father that I could not push the plunger so no medication was injected. I came out of the room and showed the syringe with the needle still on to MA. She could not push the plunger either. I went into the lab and got a new needle. I went back into the room and administered the HPV 9 vaccine successfully. No medication went into the patient during the first injection. When the patient came up to check out, he complained of feeling faint. I gave him orange juice and graham crackers. He was placed in a room and Dr. went in to evaluate him. The father felt that I had given him 2 doses of the HPV 9 vaccine because I had to inject him twice. I tried to reassure him that only one dose was given because I was unable to push any medication out of the syringe the first time.
Pt Mother provided wrong date of birth for pt. she is currently 11 years old and has received both doses of Pfizer vaccine.